Preferred Label : busulfan;

MeSH definition : An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen.;

MeSH synonym : busulphan;

CISMeF synonym : GlaxoSmithKline brand of busulfan; busulfan GlaxoSmithKline brand; busulfan orphan brand; busulfan wellcome brand; glaxo wellcome brand of busulfan; orphan brand of busulfan; wellcome brand of busulfan;

DeCS synonym : Myl ran;

MeSH hyponym : myléran; myelosan; busulfex; glyzophrol; mylecytan; myleran; busulfan wellcome; Wellcome, Busulfan;

Related MeSH term : n-Butane-1,3-di(methylsulfonate);

MeSH CAS label : 1,4-Butanediol, dimethanesulfonate;

MeSH Related Number : 55-98-1 (Busulfan);

Registry Number MeSH : 55-98-1;

Wikipedia link : https://en.wikipedia.org/wiki/Busulfan;

Codes EINECS : 200-250-2;

Is substance : O;

UNII : G1LN9045DK;

InChIKey : COVZYZSDYWQREU-UHFFFAOYSA-N;

Details


Main resources

You can consult :

An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen.

https://www.has-sante.fr/jcms/p_3196682/fr/trecondi
2020
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
treosulfan
treosulfan
infusions, intravenous
drug therapy, combination
fludarabine
transplantation conditioning
hematopoietic stem cell transplantation
allografts
child
infant
adolescent
adult
hematologic neoplasms
treosulfan
busulfan
busulfan
busulfan
vidarabine
vidarabine

---
https://www.ema.europa.eu/en/medicines/human/EPAR/trecondi
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treosulfan
treosulfan
transplantation conditioning
hematopoietic stem cell transplantation
allografts
adult
adolescent
infant
child
orphan drug production
infusions, intravenous
drug therapy, combination
antineoplastic agents, alkylating
antineoplastic agents, alkylating
pregnancy
breast feeding
fertility
treosulfan
survival analysis
drug evaluation, preclinical
busulfan
busulfan
busulfan

---
https://www.has-sante.fr/portail/jcms/c_2858905/fr/busulfan-accord
2018
false
false
false
France
French
evaluation of the transparency committee
busulfan
busulfan

---
https://www.has-sante.fr/portail/jcms/c_2858754/fr/busulfan-tillomed
2018
false
false
false
France
French
evaluation of the transparency committee
busulfan
busulfan

---
http://www.has-sante.fr/portail/jcms/c_2733392/fr/myleran
http://www.has-sante.fr/portail/jcms/c_2733392/fr/myleran-busulfan-antineoplasique
2016
false
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
busulfan
busulfan
busulfan
antineoplastic agents, alkylating
antineoplastic agents, alkylating
treatment outcome
administration, oral
leukemia, myelogenous, chronic, bcr-abl positive
insurance, health, reimbursement
transplantation conditioning
hematopoietic stem cell transplantation
myeloablative agonists
myeloablative agonists

---
http://www.has-sante.fr/portail/jcms/c_2658645/fr/busilvex
2016
false
France
French
myeloablative agonists
evaluation of the transparency committee
infusions, intravenous
transplantation conditioning
treatment outcome
hematopoietic stem cell transplantation
adult
infant, newborn
child
adolescent
busulfan
immunosuppressive agents
busulfan

---
http://www.has-sante.fr/portail/jcms/c_2658645/fr/busilvex-busulfan
2016
false
false
false
France
French
evaluation of the transparency committee
busulfan
busulfan

---
http://www.has-sante.fr/portail/jcms/c_2036410/fr/busulfan-fresenius-kabi
2015
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
busulfan
busulfan

---
https://www.ema.europa.eu/medicines/human/EPAR/Busulfan-Fresenius-Kabi
2014
false
United Kingdom
English
French
drugs, generic
europe
myeloablative agonists
myeloablative agonists
syndication feed
child
alkylating agents
hematopoietic stem cell transplantation
busulfan
busulfan
pregnancy
breast feeding
drug interactions
alkylating agents
treatment outcome
drug evaluation
infusions, intravenous
transplantation conditioning
adult
infant, newborn
adolescent
drug approval
aged
drug evaluation, preclinical
drug storage
drug compounding
busulfan
package leaflet
summary of product characteristics
drug evaluation

---
https://www.ema.europa.eu/medicines/human/EPAR/Busilvex
2012
false
United Kingdom
English
French
syndication feed
child
alkylating agents
hematopoietic stem cell transplantation
busulfan
busulfan
pregnancy
breast feeding
drug interactions
alkylating agents
treatment outcome
drug evaluation
orphan drug production
infusions, intravenous
transplantation conditioning
adult
infant, newborn
adolescent
drug approval
drug labeling
aged
drug evaluation, preclinical
drug storage
drug compounding
busulfan
package leaflet
summary of product characteristics
drug evaluation

---
http://www.e-cancer.fr/Patients-et-proches/Les-cancers/Les-cancers-chez-l-enfant/Les-cancers-de-l-enfant
2011
true
France
French
practice guideline
guidelines for drug use
Bortezomib
Bevacizumab
Rituximab
idarubicin
daunorubicin
cytarabine
taxoids
child
neoplasms
antineoplastic agents
carmustine
busulfan
topotecan
arabinonucleosides
adenine nucleotides
arsenicals
oxides
azacitidine
antibodies, neoplasm
Docetaxel
Arsenic Trioxide
Clofarabine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64700734
2008
France
French
busulfan
transplantation conditioning
myeloablative agonists
myeloablative agonists
immunosuppressive agents
immunosuppressive agents
antineoplastic agents, alkylating
tablets
drug approval
busulfan
drug labeling
administration, oral
leukemia, myelogenous, chronic, bcr-abl positive
antineoplastic agents, alkylating
adult
child
alkylating agents
drug interactions
pregnancy
breast feeding
alkylating agents
drug screening assays, antitumor
hematopoietic stem cell transplantation
busulfan
summary of product characteristics
package leaflet

---
http://www.aboutkidshealth.ca/Fr/HealthAZ/Drugs/Pages/Busulfan.aspx
2008
Canada
popular works
drug information
child
busulfan

---
http://www.meddispar.fr/medicaments/3692317
2008
France
French
administration, oral
busulfan
tablets
drug prescriptions
legislation, drug
continuity of patient care
drug monitoring
busulfan
drug information

---
http://www.has-sante.fr/portail/display.jsp?id=c_601863
http://www.has-sante.fr/portail/display.jsp?id=c_601862
2007
France
French
Contraindications, Procedure
busulfan
leukemia, myelogenous, chronic, bcr-abl positive
myeloablative agonists
hematopoietic stem cell transplantation
antineoplastic agents, alkylating
busulfan
myeloablative agonists
antineoplastic agents, alkylating
drug interactions
pregnancy
busulfan
myeloablative agonists
antineoplastic agents, alkylating
adult
child
administration, oral
tablets
continuity of patient care
busulfan
antineoplastic agents, alkylating
myeloablative agonists
transplantation conditioning
busulfan
guidelines for drug use
Contraindications, Drug

---
http://www.has-sante.fr/portail/display.jsp?id=c_400933
2006
France
French
adult
child
transplantation conditioning
antineoplastic agents, alkylating
myeloablative agonists
busulfan
alkylating agents
tablets
insurance, health, reimbursement
immunosuppressive agents
administration, oral
leukemia, myelogenous, chronic, bcr-abl positive
hematopoietic stem cell transplantation
busulfan
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_244830
2004
France
French
busulfan
immunosuppressive agents
busulfan
guidelines for drug use

---
Nous contacter.
24/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.